DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
WES 的药物开发和生物多样性保护
基本信息
- 批准号:2866914
- 负责人:
- 金额:$ 46.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2003-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
West-central Africa contains the largest moist equatorial forest on the
continent, indeed the second largest continuous tropical rain-forest in
the world (3 million square km). The species richness of this region and
its importance as a center for plant endemism makes it a key global center
for biodiversity conservation. It is a unique area with great potential as
a source of new molecular leads for drug development. The forest is
currently facing major threats, including increased pressure from a
growing human population and the destructive practices of logging and
other commercial industry.
This ICBG proposes to demonstrate that sustainable drug development is a
viable alternative to such destructive activities as a source of income
for local communities. This plan will encourage communities to protect
their own resources. Our research design emphasizes the development of
drugs for tropical diseases such as malaria and leishmaniasis as well as
high-quality, affordable herbal medicines. We are also searching for new
anti-HIV, anti-cancer and CNS drugs, as well as crop protection agents.
The ICBG strategy is to use data from field ethnobotanical and
ethnomedical surveys, plus biochemical information from the literature, to
develop a prioritized list of plants for investigation. Such focus has
been shown in our earlier work to markedly enhance the probability of
discovering active lead compounds.
We have established a 50-ha biodiversity plot in Cameroon as well as a
network of 1-ha plots throughout Cameroon and Nigeria in unique vegetative
zones in order to obtain long-term biological inventory and ecological
dynamics data. A 50-ha plot in Nigeria is proposed in the present funding
cycle. A database will link biochemical, ethnobotanical, economic and
ecological data to allow the ICBG to determine the sustainability of long-
term harvest of potentially valuable plants. Training, capacity building
and infrastructure enhancement will be provided in all aspects of the
project. The networks developed during the initial funding cycle will
ensure that this project becomes a sustainable program which can operate
and grow independently of this Group.
非洲中西部拥有地球上最大的赤道湿润森林
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN G SCHUSTER其他文献
BRIAN G SCHUSTER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN G SCHUSTER', 18)}}的其他基金
DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
WES 的药物开发和生物多样性保护
- 批准号:
6332234 - 财政年份:1998
- 资助金额:
$ 46.8万 - 项目类别:
DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
WES 的药物开发和生物多样性保护
- 批准号:
6594811 - 财政年份:1998
- 资助金额:
$ 46.8万 - 项目类别:
DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
WES 的药物开发和生物多样性保护
- 批准号:
6394907 - 财政年份:1998
- 资助金额:
$ 46.8万 - 项目类别:
DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
WES 的药物开发和生物多样性保护
- 批准号:
6530079 - 财政年份:1998
- 资助金额:
$ 46.8万 - 项目类别:
DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
WES 的药物开发和生物多样性保护
- 批准号:
6805468 - 财政年份:1998
- 资助金额:
$ 46.8万 - 项目类别:
DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
WES 的药物开发和生物多样性保护
- 批准号:
6078344 - 财政年份:1998
- 资助金额:
$ 46.8万 - 项目类别:
DRUG DEVELOPMENT AND CONSERVATION OF BIODIVERSITY IN WES
WES 的药物开发和生物多样性保护
- 批准号:
6188422 - 财政年份:1998
- 资助金额:
$ 46.8万 - 项目类别:
相似海外基金
International cooperative study for spatial-temporal disease clustering and risk factors on emerging infectious diseases
新发传染病时空疾病聚集性及危险因素国际合作研究
- 批准号:
20KK0218 - 财政年份:2020
- 资助金额:
$ 46.8万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
Molecular Pathological Analysis in Salivary Duct Carcinoma from the perspective on the Development of the Personalized Treatments: A Large Multicenter Cooperative Study.
从个性化治疗发展的角度进行唾液管癌的分子病理学分析:一项大型多中心合作研究。
- 批准号:
17K08705 - 财政年份:2017
- 资助金额:
$ 46.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Global Cooperative Study on Quality Assurance of Career Education through Writing Development
通过写作发展保证职业教育质量的全球合作研究
- 批准号:
24530966 - 财政年份:2012
- 资助金额:
$ 46.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Alzheimer's Disease Cooperative Study - Project #2
阿尔茨海默病合作研究 - 项目
- 批准号:
245483 - 财政年份:2010
- 资助金额:
$ 46.8万 - 项目类别:
Operating Grants
Alzheimer's Disease Cooperative Study - Project #4
阿尔茨海默病合作研究 - 项目
- 批准号:
245485 - 财政年份:2010
- 资助金额:
$ 46.8万 - 项目类别:
Operating Grants
Alzheimer's Disease Cooperative Study #5
阿尔茨海默病合作研究
- 批准号:
245486 - 财政年份:2010
- 资助金额:
$ 46.8万 - 项目类别:
Operating Grants
Alzheimer's Disease Cooperative Study - Project #3
阿尔茨海默病合作研究 - 项目
- 批准号:
245484 - 财政年份:2010
- 资助金额:
$ 46.8万 - 项目类别:
Operating Grants
Alzheimer's Disease Cooperative Study - Project #1
阿尔茨海默病合作研究 - 项目
- 批准号:
245482 - 财政年份:2010
- 资助金额:
$ 46.8万 - 项目类别:
Operating Grants














{{item.name}}会员




